Cosciens Biopharma Says Phase 3 DETECT-Trial Top-line Results Show Efficacy Standpoint Not Met

MT Newswires · Aug 27 20:13

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Cosciens Biopharma Says Phase 3 DETECT-Trial Top-line Results Show Efficacy Standpoint Not Met

Risk Disclaimer